Art

J-GLOBAL ID：201302215790713118   Reference number：13A0007561

Immunohistochemical analysis of thymic carcinoma focusing on the possibility of molecular targeted and hormonal therapies

分子標的療法とホルモン療法の可能性に注目した胸腺癌の免疫組織化学的分析

Author (10)： OMATSU Mutsuko (Showa Univ. Northern Yokohama Hospital, Yokohama, JPN) ,  KUNIMURA Toshiaki (Showa Univ. Northern Yokohama Hospital, Yokohama, JPN) ,  MIKOGAMI Tetsuya (Showa Univ. Northern Yokohama Hospital, Yokohama, JPN) ,  HAMATANI Shigeharu (Showa Univ. Northern Yokohama Hospital, Yokohama, JPN) ,  SHIOKAWA Akira (Showa Univ. Northern Yokohama Hospital, Yokohama, JPN) ,  MASUNAGA Atsuko (Showa Univ. Fujigaoka Hospital, Yokohama, JPN) ,  KITAMI Akihiko (Showa Univ. Northern Yokohama Hospital, Yokohama, JPN) ,  SUZUKI Takashi (Showa Univ. Northern Yokohama Hospital, Yokohama, JPN) ,  KADOKURA Mitsutaka (Showa Univ. School of Medicine, Tokyo, JPN) ,  MOROHOSHI Toshio (Showa Univ. School of Medicine, Tokyo, JPN)
Material： General Thoracic and Cardiovascular Surgery  (Gen Thorac Cardiovasc Surg)
Volume： 60  Issue： 12  Page： 803-810  Publication year： Dec. 10, 2012 
JST Material Number： Z0767A  ISSN： 1863-6705  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： pathologic diagnosis

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=13A0007561&from=J-GLOBAL&jstjournalNo=Z0767A") }}

JST classification (2)： Tumors(=neoplasms)of endocrine system  (GL04000P) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Reference (30)：

• STROBEL, P. Thymoma and thymic carcinoma molecular pathology and target therapy. J Thorac Oncol. 2010, 5, S286-S290
• BASELGA, J. Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J Clin Oncol. 1996, 14, 737-744
• SALTZ, LB. Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. J Clin Oncol. 2004, 22, 1201-1208
• WANG, SJ. CD44 variant isoforms in head and neck squamous cell carcinoma progression. Laryngoscope. 2009, 119, 1518-1530
• YOSHIMURA, R. Expression of peroxisome proliferator-activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists. Int J Cancer. 2003, 104, 597-602

Terms in the title (7)： 分子標的療法 ,  ホルモン療法 ,  可能性 ,  注目 ,  胸腺癌 ,  免疫組織化学 ,  分析